StocksFin Logo
NASDAQ | Healthcare | Healthcare Plans
Twist Bioscience Corporation country of incorporation
|
|
Ms. Emily Leproust
|
989 employees
NASDAQ | Healthcare | Diagnostics & Research
Q322 reported Nov 3, 2022 Reporting Period
$360.35M 22.8% vs. Q321 Revenues Q322
13.18% -2% vs. Q321 Gross Profit Margin
-11.17% ! 28.5% vs. Q321 Net Profit Margin
98.57M 663.3% vs. Q321 Free Cash Flow Q322
$-0.22 ! 15.4% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Q123 reported Feb 7, 2023 Reporting Period
$54.24M 29.1% vs. Q122 Revenues Q123
45.72% 28.4% vs. Q122 Gross Profit Margin
-77.1% ! 28.9% vs. Q122 Net Profit Margin
-65.89M ! -41.2% vs. Q122 Free Cash Flow Q123
$-0.74 ! 18.7% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Dec 31, 2022
Quick Ratio
1.93
5.76
Current Ratio
2.03
6.46
Cash Ratio
1.67
3.78
Price to Book
7.92
1.8
Price to Sales
5.98
24.78
Price to Earnings
-13.39
-8.03